Skip to main content
Log in

Copy Number Variants and Polygenic Risk Scores Predict Need of Care in Autism and/or ADHD Families

  • Original Paper
  • Published:
Journal of Autism and Developmental Disorders Aims and scope Submit manuscript

Abstract

Autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) are highly heritable neurodevelopmental disorders that frequently co-occur. Both rare and common genetic variants are important for ASD and ADHD risk but their combined contribution to clinical heterogeneity is unclear. In a sample of 39 ASD and/or ADHD families we estimated the overall variance explained by known rare copy number variants (CNVs) and polygenic risk score (PRS) from common variants to be 10% in comorbid ASD/ADHD, 4% in ASD and 2% in ADHD. We show that burden of large, rare CNVs and PRS is significantly higher in adult ASD and/or ADHD patients with sustained need for specialist care compared to their unaffected relatives, while affected relatives fall in-between the two.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

Download references

Funding

The research leading to these results has received funding from The Lundbeck Foundation No R208-2015-3951 and Fonden for Faglig Udvikling af Speciallægepraksis No 38850/16.

Author information

Authors and Affiliations

Authors

Contributions

SLB contributed to collecting and analysing data, manuscript writing. JLB, KDJ and AKP participated in the supervising data collection. VA conceived the polygenic risk score implementation. AB and TW contributed to supervising data analysis and manuscript writing.

Corresponding author

Correspondence to Sonja LaBianca.

Ethics declarations

Conflict of interest

Thomas Werge has served as a lecturer for and consultant to H. Lundbeck A/S. Jette LaBianca has served at the advisory board for H. Lundbeck A/S and as lecturer for H. Lundbeck A/S, Shire and Servier. Klaus Damgaard Jakobsen has been a consultant for AstraZeneca, on advisory board for Bristol Myers Squibb and received speaker's honoraria from Lundbeck Pharma. Anne Katrine Pagsberg, Vivek Appadurai, Alfonso Buil and Sonja LaBianca report no conflicts of interest.

Ethical Approval

All procedures performed in this study involving human participants were in accordance with the ethical standards of the National Committee on Health Research Ethics in Denmark (Protocol: H_B_2009_026) and with the 1964 Helsinki declaration and its later amendments.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 470 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

LaBianca, S., LaBianca, J., Pagsberg, A.K. et al. Copy Number Variants and Polygenic Risk Scores Predict Need of Care in Autism and/or ADHD Families. J Autism Dev Disord 51, 276–285 (2021). https://doi.org/10.1007/s10803-020-04552-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10803-020-04552-x

Keywords

Navigation